SOLICITATION NOTICE
R -- Technical Assistance and Advice of Development of FDA's CVM Annual Field Workiplan
- Notice Date
- 7/31/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA1059485-09
- Archive Date
- 8/29/2009
- Point of Contact
- Patricia Wright, Phone: 301-827-7217
- E-Mail Address
-
patricia.wright@fda.hhs.gov
(patricia.wright@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This announcement constitutes the only solicitation and a written solicitation will not be issued. This solicitation is issued as a Request for Quotation (RFQ). The announcement constitutes the only solicitation and a written solicitation with not be issued. The NAICS code, 541690. This is a 100% small business set-aside. The Government reserves the right to award a purchase order without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the best value and discussions are not necessary. The Food and Drug Administration (FDA) intends to award a purchase order for Technical Assistance and Advice on the Development of the FDA Center for Veterinary Medicine’s (CVM) Annual Field Work Plan. 1. STATEMENT OF WORK Independently and not as an agent of the Government, the contractor shall furnish the necessary services and personnel, and otherwise do all things necessary for or incident to the performance of the work as described below. Description of Work/Deliverables The contractor shall be responsible for providing detailed technical assistance and advice throughout the development of CVM’s portion of the Annual Field Work Plan. The contractor shall draft the final work plan document that will go to Office of Regulatory Affairs (ORA). We anticipate that the total hours needed to complete the tasks associated with this contract will be 407. The majority of the work for the contractor shall be completed offsite. The contractor shall be required to meet periodically in person and via telephone with CVM Program managers regarding contract issues. Government equipment will not be utilized to complete this contract. The contractor shall work closely with CVM staff to develop the Center’s input in to the ORA Annual Field Work plan. The contractor shall be required to perform the following tasks: (1) review and comment on the Program Activity Data (PAD) table, (2) develop a draft response to the annual “Call” document, (3) review, comment, and draft responses to all work plan drafts received from ORA during the year; (4) provide briefings for the CVM Field Committee and Center management on resources utilization/projections, (5) assist the Center in the development and expansion of resource planning for the Bovine Spongiform Encephalopathy (BSE) and Animal Feed program areas, (6) meet with Center Program Managers to assess program resource needs for the upcoming year; (7) advise Center management on the Field’s annual utilization of program resources, (8) work closely with the Veterinary Field Committee, ORA’s Division of Field Investigations, Division of Import Operations, Division of Field Sciences, Division of Federal/State Relations, and Center Management to negotiate resource changes as they become necessary. 2. PERIOD OF PERFORMANCE Base Year – September 1, 2009 to August 31, 2010 Option Year 1 - September 1, 2010 to August 31, 2011 Option Year 2 - September 1, 2011 to August 31, 2012 Option Year 3 - September 1, 2012 to August 31, 2013 Option Year 4 - September 1, 2013 to August 31, 2014 3. LOCATION The contractor shall perform most contract duties at the contractor’s location. The contractor shall be required to attend meetings at the Center or at offsite meeting places. 4. EQUIPMENT The contractor shall be required to perform work using “contractor owned” equipment. No “government owned” equipment will be provided. 5. ESTIMATE OF LEVEL OF EFFORT The Government estimates that the total level of effort required will be approximately 407 labor hours. This information is provided as an estimate for proposal purposes only and should not be considered as a directive to offerors. 6. EVALUATION FACTORS FOR AWARD In determining which offer represents the best value (i.e., labor hours, special features, administrative costs) to meet the Government’s needs, the Government shall evaluate responses using the following evaluation criteria that are listed in descending order of priority: The technical proposal will receive paramount consideration in the selection of the offeror for this acquisition. In the event that the technical evaluation reveals that two or more offerors are approximately equal in the technical ability, then cost may become a significant factor in determining award. In any event, the government reserves the right to make an award based on a best value determination, cost and other factors considered. A. EVALUATION CRITERIA The evaluation will be based on the completeness, thoroughness and demonstrated capabilities of the prospective offeror in relation to the needs of the Statement of Work as set forth in the RFQ. Each proposal must document the feasibility of successful implementation of the requirements of the RFQ Offerors must submit information sufficient to evaluate their proposals based on the detailed criteria listed below. (1) Qualifications of Personnel The offeror ‘s ability to demonstrate they have detailed knowledge of the FDA/CVM Compliance Program planning and evaluation process to assess program resource needs for the upcoming year and discuss the needs with the CVM Program managers. The offeror’ ability to demonstrate that they have detailed knowledge of FDA’s work plan process in order to review and comment on the PAD table, develop a draft response to the annual work plan “Call” document and review, comment, and draft responses to all work plan associated requests received from ORA during the year as stated in the scope of work. (2) Technical Approach The offeror’s ability to demonstrate their detailed knowledge of CVM risk based work planning approaches per compliance program area. The offeror’s ability to demonstrate that they have the detailed knowledge of FDA’s Domestic and Import programs so that they are able to meet with ORA to develop and negotiate program operations modules, and to determine appropriate data to use in developing operations modules. The offerorr’s ability to demonstrate their detailed knowledge of CVM in risk based planning for several program areas. The offeror’s ability to demonstrate that they have the detailed knowledge needed to be able to assist CVM/OM with budget projections and program area data related to the PAD. The offeror shall also demonstrate that they have detailed knowledge of FDA’s Domestic and Import programs so that they are able to meet with ORA to develop and negotiate program operations modules and to determine appropriate data for use in developing operations modules. (3) Past Performance The government will assess the relative risk associated with each offeror. Performance risks are those associated with an offeror's likelihood of success in performing the contract requirements as indicated by that offeror's record of past performance. Offerors shall submit a list and description of the last three (3) contracts completed during the past three years and all contracts currently in process. Offerors shall furnish documentation of past performance by having three (3) Past Performance Survey Questionnaires completed by customers and provided with their proposal. In cases where: (i) an offeror lacks relevant performance history; (ii) information on performance is not available; or (iii) an offeror is a member of a class of offerors where there is provision not to rate the class against a subfactor; Then the offeror will not be evaluated favorably or unfavorably on performance and shall receive a neutral rating. (4) Quality Control Procedures The offeror’s ability to identify means of final draft quality control to ensure that anything submitted is relatively free of typographical errors and any other quality control needed for the statement of work. detail quality control measures to be used to ensure that all work products submitted are relatively free of typographical errors and other measures taken to ensure a high quality finished product. 7. PRICING FDA will evaluate the offeror’s submission/proposal on the basis of cost realism which is defined as the offeror’s ability to project costs which are reasonable and indicate that the offeror understands the nature and extent of work to be performed. The offeror’s fixed price shall be provided for the entire period of performance and list the labor hours and hourly rate to perform the work described in the statement of work. 8. CCR Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. 9. OFFERS DUE All quotes are due to Patricia Wright via email at: patricia.wright@fda.hhs.gov not later than August 14, 2009. 4:30 PM EST. QUESTIONS DEADLINE: All questions are to be submitted via email to patricia.wright@fda.hhs.gov no later than August 6, 2009, 4:30 PM EST. 10. PROVISIONS AND CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, FAR 52.232-33, 52.217-8 and 52.217-9. Clauses and provisions are incorporated by reference and apply to this acquisition. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA1059485-09/listing.html)
- Record
- SN01896039-W 20090802/090801001520-60d058fbf90a00e2d30bddb53e670033 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |